Staples, Carter’s, Nektar, Vocus High Demand Stock Movers Feb. 29th

Staples, Inc. (NASDAQ:SPLS): In North American retail store network, expects no net store growth in 2012 on the Q4 earnings conference call. Shares of Staples, Inc. are trading 6.59% lower today.

Carter’s, Inc. (NYSE:CRI): Reports Q4 OshKosh B’gosh retail segment sales up 11.9% to $89.3M. Shares of Carter’s, Inc. are trading 9.98% higher today.

Nektar Therapeutics (NASDAQ:NKTR): Nektar Therapeutics announced that it agreed to sell to Royalty Pharma its royalties on future sales of CIMZIA, under Nektar’s agreement with UCB Pharma, and MIRCERA, under Nektar’s agreement with Roche. In consideration for the sale, Royalty Pharma will pay Nektar an aggregate cash payment of $124.0M. Nektar intends to use the net proceeds of the transaction towards the repayment of its $215M of convertible debt. For the twelve month period ended December 31, 2011, Nektar recognized $8.3M in aggregate royalties from net sales of CIMZIA and MIRCERA. Shares of Nektar Therapeutics are trading 10.3% higher today.

Vocus, Inc. (NASDAQ:VOCS): Vocus disclosed last night that it entered into a merger agreement with iContact’s equityholders pursuant to which the company will merge with and into iContact. Under the terms of the deal, Vocus acquired iContact for approximately $91M of cash, $9M of common stock and $79M of redeemable convertible preferred stock, aggregating $169M of total consideration, net of $10M cash acquired. Shares of Vocus, Inc. are trading 37.25% lower today.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: Derek Hoffman at staff.writers@wallstcheatsheet.com

To contact the editor responsible for this story: Damien Hoffman at editors@wallstcheatsheet.com